Virtus LifeSci Biotech Clinical Trials ETF
Virtus Investment Partners, Inc. BBC ETF
| BBC Price | $40.63 |
Market Cap | $37.27M |
| Annual Dividend Yield | 1.62% |
Annual Dividend | $0.66 |
| Yearly Management Fee | 0.79% |
Asset Class | Equity |
| Focus | Health care |
Category | Sector, Health Care |
| Niche | Life sciences tools & services |
Last 24h Volume | $13.99K |
| Portfolio Management Company | Virtus Investment Partners, Inc. |
Discount/Premium to NAV | -0.17% |
| Inception Date | Dec 16, 2014 |
Market Cap Rank | 3291 |
| Monthly AUM Growth | 25.21% |
Holdings Region | North America |
| Management Style | Passive |
Leverage | Non-Leveraged |
Virtus LifeSci Biotech Clinical Trials ETF is an ETF issued by Virtus Investment Partners, Inc. on Dec 16 2014.
The main focus of this ETF, which is in the "Equity" asset class, is determined as "Health care".
As of today, the price of BBC ETF according to its net asset value is discounted at -0.17%.
While the total value of the fund shows $7.5M increase compared to the previous month, its price is traded daily at a increase of 0.67%.
The annual dividend yield of BBC ETF is 1.62%, whereas its main asset area is North America.
BBC ETF, whose 24-hour total volume is $13.99K, has experienced a $5.89M cash inflow in the last month.
In addition, Virtus LifeSci Biotech Clinical Trials ETF's one-year net asset value total return is 84.68%.
BBC ETF Returns
| Daily |
Weekly |
Monthly |
3 Mo |
6 Mo |
YTD |
Yearly |
| 0.67% |
2.50% |
2.34% |
32.78% |
83.43% |
3.83% |
86.72% |
BBC ETF NAV Total Return
| Monthly |
3 Mo |
YTD |
Yearly |
3 Years |
5 Years |
| 3.34% |
33.96% |
4.52% |
84.68% |
53.91% |
-23.22% |
BBC ETF Comments
no comments yet